Trovirdine hydrochloride

Trovirdine hydrochloride hydrochloride hydrochloride potently inhibits the activity of wild-type HIV-1 reverse transcriptase with an IC₅₀ of 0.012 μM; it also inhibits the replication of wild-type HIV-1 in MT-4 cells with an IC₅₀ of 0.013 μM^[1].
Trovirdine hydrochloride hydrochloride hydrochloride exhibits IC₅₀ values of 0.34 μM and 0.33 μM against HIV‑1 RT Tyr181→Cys and HIV‑1 RT Leu100→Ile mutants with 28‑fold and 27‑fold resistance respectively. In MT‑4 cells, Trovirdine hydrochloride hydrochloride hydrochloride shows IC₅₀ values of 3.90 μM, 24.5 μM and 1.90 μM for HIV‑1 Ile100, Asn103 and Cys181 mutant strains, with resistance factors >300‑fold, >1×10³‑fold and >140‑fold correspondingly^[1].

Trovirdine hydrochloride hydrochloride hydrochloride inhibits the activity of wild-type HIV‑1 reverse transcriptase (measured by the dCTP incorporation assay) with an IC₅₀ of 0.03 μM; it also inhibits the activities of the HIV‑1 RT Tyr181→Cys mutant and HIV‑1 RT Leu100→Ile mutant, with corresponding IC₅₀ values of 0.53 μM and 0.34 μM, respectively^[1].

Trovirdine hydrochloride hydrochloride hydrochloride (6 days) inhibits the replication of wild-type HIV-1 as well as HIV-1 Ile100, Asn103, and Cys181 mutants in MT-4 cells in the context of combination testing with ddI, with corresponding IC₅₀ values of 0.019 μM, 4.0 μM, 13.7 μM, and 0.87 μM^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.